The US Food and Drug Administration released draft guidance on 22 December on how researchers can use smartphones, wearables, and other digital health technologies to remotely collect data from clinical study participants on a continuous basis.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?